User menu

Leuprolide acetate 1-, 3- and 6-monthly depot formulations in androgen deprivation therapy for prostate cancer in nine European countries: evidence review and economic evaluation.

Bibliographic reference Wex, Jaro ; Sidhu, Manpreet ; Odeyemi, Isaac ; Abou-Setta, Ahmed M ; Retsa, Peny ; et. al. Leuprolide acetate 1-, 3- and 6-monthly depot formulations in androgen deprivation therapy for prostate cancer in nine European countries: evidence review and economic evaluation.. In: ClinicoEconomics and outcomes research : CEOR, Vol. 5, p. 257-69 (2013)
Permanent URL http://hdl.handle.net/2078.1/132670